- Medley.ai develops diagnostic and prognostic tests for guiding personalized treatment options for mental health disorders.
- Our first product is an EEG biomarker-test to predict relapse and treatment response in depression and addiction disorders.
Every human is unique and experiences unique things in life. This uniqueness reflects in our mental health. Our mission is to personalize mental healthcare and help people with mental health problems to become their unique self again.
The products of our company are inspired by research on transdiagnostic symptom clusters in addition to the regular DSM5 diagnostics.
Medley.ai joined the Health RampUp program of the Bluehealth Innovation Center Belgium, founded by Microsoft and co-hosted by PwC and IMEC.